Literature DB >> 25278092

B7-1 immunostaining in proteinuric kidney disease.

Christopher P Larsen1, Nidia C Messias2, Patrick D Walker2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25278092     DOI： 10.1053/j.ajkd.2014.07.023

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  17 in total

1.  B7-1 Is Not Induced in Podocytes of Human and Experimental Diabetic Nephropathy.

Authors:  Elena Gagliardini; Rubina Novelli; Daniela Corna; Carlamaria Zoja; Barbara Ruggiero; Ariela Benigni; Giuseppe Remuzzi
Journal:  J Am Soc Nephrol       Date:  2015-08-28       Impact factor: 10.121

Review 2.  Minimal change disease and idiopathic FSGS: manifestations of the same disease.

Authors:  Rutger J Maas; Jeroen K Deegens; Bart Smeets; Marcus J Moeller; Jack F Wetzels
Journal:  Nat Rev Nephrol       Date:  2016-10-17       Impact factor: 28.314

3.  Costimulatory blockade: A novel approach to the treatment of glomerular disease?

Authors:  Pasquale Esposito; Teresa Rampino; Antonio Dal Canton
Journal:  World J Methodol       Date:  2015-06-26

4.  Urinary CD80: a biomarker for a favorable response to corticosteroids in minimal change disease.

Authors:  Gabriel Cara-Fuentes; Miguel A Lanaspa; Gabriela E Garcia; Mindy Banks; Eduardo H Garin; Richard J Johnson
Journal:  Pediatr Nephrol       Date:  2018-03-01       Impact factor: 3.714

5.  Glomerular B7-1 staining: toward precision medicine for treatment of recurrent focal segmental glomerulosclerosis.

Authors:  Chia-Shi Wang; William E Smoyer; Gabriel Cara-Fuentes
Journal:  Pediatr Nephrol       Date:  2022-06-20       Impact factor: 3.714

Review 6.  Podocyte-actin dynamics in health and disease.

Authors:  Luca Perico; Sara Conti; Ariela Benigni; Giuseppe Remuzzi
Journal:  Nat Rev Nephrol       Date:  2016-08-30       Impact factor: 28.314

7.  Podocyte Expression of B7-1/CD80: Is it a Reliable Biomarker for the Treatment of Proteinuric Kidney Diseases with Abatacept?

Authors:  David J Salant
Journal:  J Am Soc Nephrol       Date:  2015-09-23       Impact factor: 10.121

Review 8.  CTLA4-Ig in B7-1-positive diabetic and non-diabetic kidney disease.

Authors:  Roberto Bassi; Alessia Fornoni; Alessandro Doria; Paolo Fiorina
Journal:  Diabetologia       Date:  2015-09-26       Impact factor: 10.122

9.  Interaction of CD80 with Neph1: a potential mechanism of podocyte injury.

Authors:  Bhavya Khullar; Renu Balyan; Neelam Oswal; Nidhi Jain; Amita Sharma; Malik Z Abdin; Arvind Bagga; Shinjini Bhatnagar; Nitya Wadhwa; Uma Chandra Mouli Natchu; Anna George; Satyajit Rath; Vineeta Bal; Shailaja Sopory
Journal:  Clin Exp Nephrol       Date:  2017-10-11       Impact factor: 2.801

Review 10.  Biomarkers in pediatric glomerulonephritis and nephrotic syndrome.

Authors:  Gabriel Cara-Fuentes; William E Smoyer
Journal:  Pediatr Nephrol       Date:  2021-01-03       Impact factor: 3.714
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.